• Arcutis Biotherapeutics EVP, Chief Legal Officer Masaru Matsuda sold 40,000 common shares at $34.3168 each on Nov. 4, 2026.
• He exercised stock options for 40,000 common shares at $3.64 each the same day.
• A separate sale on Nov. 2, 2026, involved 1,219 common shares at $31.8634 each.
• Following the transactions, Matsuda directly held 111,289 common shares and stock options covering 136,000 shares.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Arcutis Biotherapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001628280-26-070385), on November 04, 2026, and is solely responsible for the information contained therein.